RUMI, ELISA

RUMI, ELISA  

DIPARTIMENTO DI MEDICINA MOLECOLARE  

Mostra records
Risultati 1 - 20 di 159 (tempo di esecuzione: 0.03 secondi).
Titolo Data di pubblicazione Autore(i) File
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms 1-gen-2013 Rumi, Elisa; Pietra, D; Guglielmelli, P; Bordoni, R; Casetti, I; Milanesi, C; Sant'Antonio, E; Ferretti, V; Pancrazzi, A; Rotunno, G; Severgnini, M; Pietrelli, A; Astori, C; Fugazza, E; Pascutto, C; Boveri, E; Passamonti, F; De Bellis, G; Vannucchi, A; Cazzola, Mario
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms 1-gen-2017 Rumi, Elisa; Cazzola, Mario
Allelic imbalance in CALR somatic mutagenesis 1-gen-2015 Harutyunyan, As; Jäger, R; Chen, D; Berg, T; Rumi, Elisa; Gisslinger, B; Pietra, D; Gisslinger, H; Cazzola, Mario; Kralovics, R. 5.
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 1-gen-2021 Barbui, T; De Stefano, V; Alvarez-Larran, A; Iurlo, A; Masciulli, A; Carobbio, A; Ghirardi, A; Ferrari, A; Cancelli, V; Elli, Em; Andrade-Campos, Mm; Kabat, Mg; Kiladjian, Jj; Palandri, F; Benevolo, G; Garcia-Gutierrez, V; Fox, Ml; Foncillas, Ma; Morcillo, Cm; Rumi, E; Osorio, S; Papadopoulos, P; Bonifacio, M; Cervantes, Ksq; Serrano, Ms; Carreno-Tarragona, G; Sobas, Ma; Lunghi, F; Patriarca, A; Elorza, Bn; Angona, A; Mazo, Em; Koschmieder, S; Carli, G; Cuevas, B; Hernandez-Boluda, Jc; Abadia, El; Cirici, Bx; Guglielmelli, P; Garrote, M; Cattaneo, D; Daffini, R; Cavalca, F; Bellosillo, B; Benajiba, L; Curto-Garcia, N; Bellini, M; Betti, S; Harrison, C; Rambaldi, A; Vannucchi, Am.
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. 1-gen-2020 De Stefano, V; Ghirardi, A; Masciulli, A; Carobbio, A; Palandri, F; Vianelli, N; Rossi, E; Betti, S; Di Veroli, A; Iurlo, A; Cattaneo, D; Finazzi, G; Bonifacio, M; Scaffidi, L; Patriarca, A; Rumi, E; Casetti, Ic; Stephenson, C; Guglielmelli, P; Elli, Em; Palova, M; Rapezzi, D; Erez, D; Gomez, M; Wille, K; Perez-Encinas, M; Lunghi, F; Angona, A; Fox, Ml; Beggiato, E; Benevolo, G; Carli, G; Cacciola, R; Mcmullin, Mf; Tieghi, A; Recasens, V; Isfort, S; Marchetti, M; Griesshammer, M; Alvarez-Larran, A; Vannucchi, Am; Rambaldi, A; Barbui, T.
Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies. 1-gen-2010 Passamonti, F; Rumi, Elisa; Randi, Ml; Morra, E; Cazzola, Mario
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms. 1-gen-2018 De Stefano, V; Carobbio, A; Di Lazzaro, V; Guglielmelli, P; Iurlo, A; Finazzi, Mc; Rumi, E; Cervantes, F; Elli, Em; Randi, Ml; Griesshammer, M; Palandri, F; Bonifacio, M; Hernandez-Boluda, Jc; Cacciola, R; Miroslava, P; Carli, G; Beggiato, E; Ellis, Mh; Musolino, C; Gaidano, G; Rapezzi, D; Tieghi, A; Lunghi, F; Loscocco, Gg; Cattaneo, D; Cortelezzi, A; Betti, S; Rossi, E; Finazzi, G; Censori, B; Cazzola, M; Bellini, M; Arellano-Rodrigo, E; Bertozzi, I; Sadjadian, P; Vianelli, N; Scaffidi, L; Gomez, M; Cacciola, E; Vannucchi, Am; Barbui, T.
Blast phase of essential thrombocythemia: A single center study. 1-gen-2009 Passamonti, Francesco; Rumi, Elisa; Arcaini, Luca; Elena, Chiara; Castagnola, C; Zappasodi, P; Bernasconi, Paolo; Pietra, D; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 1-gen-2009 Rumi, Elisa; Passamonti, Francesco; Pagano, L; Ammirabile, M; Arcaini, Luca; Elena, Chiara; Flagiello, A; Tedesco, R; Vercellati, C; Marcello, Ap; Pietra, D; Moratti, Remigio; Cazzola, Mario; Lazzarino, Mario
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia. 1-gen-2012 Carobbio, A; Finazzi, G; Thiele, J; Kvasnicka, Hm; Passamonti, Francesco; Rumi, Elisa; Ruggeri, M; Rodeghiero, F; Luigia Randi, M; Bertozzi, I; Vannucchi, Am; Antonioli, E; Gisslinger, H; Buxhofer Ausch, V; Gangat, N; Rambaldi, A; Tefferi, A; Barbui, T.
Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients 1-gen-2009 Boveri, E; Arcaini, Luca; Merli, M; Passamonti, F; Rizzi, S; Vanelli, L; Rumi, Elisa; Rattotti, S; Lucioni, M; Picone, C; Castello, A; Pascutto, C; Lazzarino, M; Magrini, Umberto; Paulli, M.
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 1-gen-2008 Boveri, E; Passamonti, F; Rumi, Elisa; Pietra, D; Elena, Chiara; Arcaini, Luca; Pascutto, C; Castello, Alessandro; Cazzola, Mario; Magrini, Umberto; Lazzarino, Mario
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis 1-gen-2014 Rumi, Elisa; Harutyunyan, As; Pietra, D; Milosevic, Jd; Casetti, Ic; Bellini, M; Them, Nc; Cavalloni, C; Ferretti, Vv; Milanesi, C; Berg, T; Sant'Antonio, E; Boveri, E; Pascutto, C; Astori, C; Kralovics, R; Cazzola, Mario
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles. 1-gen-2017 Zini, R; Guglielmelli, P; Pietra, D; Rumi, E; Rossi, C; Rontauroli, S; Genovese, E; Fanelli, T; Calabresi, L; Bianchi, E; Salati, S; Cazzola, M; Tagliafico, E; Vannucchi, Am; Manfredini, R
Cardiovascular events and intensity of treatment in polycythemia vera. 1-gen-2013 Marchioli, R; Finazzi, G; Specchia, G; Cacciola, R; Cavazzina, R; Cilloni, D; De Stefano, V; Elli, E; Iurlo, A; Latagliata, R; Lunghi, F; Lunghi, M; Marfisi, Rm; Musto, P; Masciulli, A; Musolino, C; Cascavilla, N; Quarta, G; Randi, Ml; Rapezzi, D; Ruggeri, M; Rumi, Elisa; Scortechini, Ar; Santini, S; Scarano, M; Siragusa, S; Spadea, A; Tieghi, A; Angelucci, E; Visani, G; Vannucchi, Am; Barbui, T.
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases 1-gen-2014 Dentali, F; Ageno, W; Rumi, Elisa; Casetti, I; Poli, D; Scoditti, U; Maffioli, M; di Minno, Mn; Caramazza, D; Pietra, D; De Stefano, V; Passamonti, F. 6.
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria. 1-gen-2017 Rumi, E; Boveri, E; Bellini, M; Pietra, D; Ferretti, Vv; Sant'Antonio, E; Cavalloni, C; Casetti, Ic; Roncoroni, E; Ciboddo, M; Benvenuti, P; Landini, B; Fugazza, E; Troletti, D; Astori, C; Cazzola, M
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis 1-gen-2014 Rumi, Elisa; Pietra, D; Pascutto, C; Guglielmelli, P; Martínez Trillos, A; Casetti, I; Colomer, D; Pieri, L; Pratcorona, M; Rotunno, G; Sant'Antonio, E; Bellini, M; Cavalloni, C; Mannarelli, C; Milanesi, C; Boveri, E; Ferretti, V; Astori, C; Rosti, V; Cervantes, F; Barosi, G; Vannucchi, Am; Cazzola, Mario
Clinical relevance of JAK2 (V617F) mutant allele burden 1-gen-2009 Passamonti, Francesco; Rumi, Elisa
Clinical relevance of murine double minute 2 single nucleotide polymorphisms 309 in familial myeloproliferative neoplasm. 1-gen-2012 Rumi, Elisa; Casetti, I; Pietra, D; Elena, Chiara; Ambaglio, I; Pascutto, C; Passamonti, F; Cazzola, Mario